We have previously shown that induced pluripotent stem (iPS) cells taken from individuals who have T2D or who have insulin resistance but without T2D, when differentiated into myoblasts, demonstrate an insulin resistance signature in vitro, indicating the ability of these cells to model the cell-intrinsic defects in insulin signaling in T2D and insulin resistance (24–26). This evidence concerns the gene INS and Insulin resistance.